Navigation Links
JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
Date:11/14/2007

- $3 Million Grant Over Three Years from Lilly Foundation Could 'Fill a

Major Gap' in Diabetes Science -

NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- The Juvenile Diabetes Research Foundation and Eli Lilly and Company announced today that they are joining together to create a $3 million research effort to accelerate the pace of research into drugs and therapies to cure diabetes and its complications by developing biomarkers -- indicators that can measure the progress of disease and the effectiveness of therapeutics.

The project -- called the JDRF-Lilly Innovative and Academic Research and Development Grants in Diabetes Biomarkers -- will be funded by a $3 million grant from the Lilly Foundation to JDRF over three years.

JDRF is one of the world's largest charitable funder of type 1 diabetes research; over the last year, JDRF has funded more than $137 million in research to cure and develop therapeutics for type 1 diabetes and its complications. Lilly is a global leader in diabetes science and treatment, dating back to the development of the world's first commercially-available insulin in the 1920s, and continues to pioneer research to develop innovative medicines to address the unmet needs of people with diabetes.

The new JDRF-Lilly project will support cutting-edge research on biomarkers for pancreatic beta cell mass and function.

Biomarkers are natural features (lab values, images, or clinical features) whose detection indicates the presence of a particular disease state, or correlates with the risk or progression of a disease; for example, elevated prostate specific antigen is a molecular biomarker for prostate cancer. Two of the best-known biomarkers are cholesterol and blood pressure levels, which denote key information about cardiovascular health. In evaluating potential therapeutics, biomarkers can also serve as "surrogate endpoints" for evaluating the clinical benefit of a treatment.

"In genera
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
10. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
11. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...RNewswire/ -- MicroCHIPS, a developer of intellige... has been named a 2010 Technology Pioneer by the W...ted for pioneering a novel medical device platform...to bridge the gap between disease monitoring and t...licability, from ,rescue, applications in diabetes...
(Date:12/3/2009)...ec. 3 Upsher-Smith Laboratories, I...c plan for central nervous system (CNS) diseases w...nally developed program for the management of epil...s proprietary formulation technology and will ente... adjunctive treatment of epilepsy patients with pa...
(Date:12/3/2009)...wire/ -- Amira Pharmaceuticals, Inc. announced t... study of AM461, the Company,s second oral selecti...eptor. ,, The interim results demonstrate tha...can be achieved with AM461. Additionally, AM461 P...file. AM461 is a back-up to Amira,s lead DP2 anta...
Breaking Medicine Technology:MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum 2Upsher-Smith Announces Milestone in Development of CNS Strategy 2Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211 2Natural seed treatment could drastically cut pesticide use 8750 1Natural seed treatment could drastically cut pesticide use 8750 2Single Port Surgeries Now Performed at University Medical Center at Princeton 4565 1Single Port Surgeries Now Performed at University Medical Center at Princeton 4565 2Rx for Africa Inc Signs Letter of Intent for Strategic Alliance with Rusan Pharma Ltd of India 48199 1Rx for Africa Inc Signs Letter of Intent for Strategic Alliance with Rusan Pharma Ltd of India 48199 2Rx for Africa Inc Signs Letter of Intent for Strategic Alliance with Rusan Pharma Ltd of India 48199 3
... Assays Validated in CLIA Laboratory, SOUTH SAN F...daq: MGRM ) today presented the results of a stud...ntify metastatic breast,cancer patients who are mo...sults were presented this week at the San Antonio ...received confirmation from the College,of Patholog...
...for the Treatment of PKU, NOVATO, Calif., Dec. 13...RN) announced today that the U.S.,Food and Drug Ad...for,Kuvan(TM) (sapropterin dihydrochloride) Tablet...e treatment of phenylketonuria (PKU). Shipments to...and BioMarin will begin,promotion of Kuvan immedia...
Other Medicine Technology:HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium 2HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium 3HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium 4HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium 5HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium 6BioMarin Announces FDA Approval for Kuvan 2BioMarin Announces FDA Approval for Kuvan 3BioMarin Announces FDA Approval for Kuvan 4BioMarin Announces FDA Approval for Kuvan 5BioMarin Announces FDA Approval for Kuvan 6BioMarin Announces FDA Approval for Kuvan 7BioMarin Announces FDA Approval for Kuvan 8
(Date:12/4/2009)...swire/ -- Herpes zoster, also known as shingles, i...d against chicken pox, according to a Kaiser Perma...c Infectious Diseases Journal. ,, The study, t...ords to identify more than 170,000 children vaccin... 2002 to 2008 in Kaiser Permanente,s Southern Cali...
(Date:12/3/2009)... increase of more than 15 percent since 2007, the ... in its history, but also as a sign of the organiz...eriencing a decline in membership due to the strug...zations across the nation are suffering significan...owth, signaling that physicians see considerable v...
(Date:12/3/2009)...wswire/ -- The development of University Medical C... milestone today with a "topping out" ceremony, ma...t the new hospital that will replace University Me...ttp://www.newscom.com/cgi-bin/prnh/20091203/NY2097..., tradition in which a steel beam carrying an ever...
(Date:12/3/2009)...e-Asia/ -- Long believed to provide a variety of,h...ingredients in global,cuisine, has seen increased ... The timing of this ginger demand increase coincid...ressures in a way that has speculators wondering a...eria over garlic. Garlic, also,believed to have fl...
(Date:12/3/2009)...SNewswire/ -- The American Association of Homes an...te for passing Sen. Michael Bennet,s (D-Colo.) ame...anteed benefits, and strengthens Medicare by keepi...ver tsunami of retiring baby boomers fast approach...tion currently before Congress to address Medicare...
Breaking Medicine News(10 mins):Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Florida Medical Association Marks Record Membership Growth 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4Health News:Ginger Prices Could Skyrocket on H1N1 Fears 2
...ABT ),today announced the start of SPIRIT Small Ve...f the XIENCE V(TM) Everolimus Eluting Coronary Ste...ysicians an option for treating,coronary artery di...the United States, where it quickly,became the mar...
...where data doesn,t match WHO reports , , W...ion fewer children are immunized against diphtheri...ividual nations and World Health Organization/UNIC...ashington in Seattle researchers calculated that 5...
...ial tasks, including mental rotation, which is the... if rotated in space. Now, a University of Iowa st...lity and the structure of the parietal lobe, the b...ng proportionally thicker cortexes or "grey matter...
...Ltd. announced today that it has settled all ongoi...ne tablets, the generic version of Schering-Plough...ms of the settlement, Lupin Ltd. will be licensed ...rcumstances. , , Lupin had earlier filed a P...
...differently,than men. That,s why Ft. Bragg, CA-bas...e nation,s first mattress specifically for women. ...itively recognizes the,difference between straight...bone structure is different," continues Turner. "...
...sa was only two when he became an orphan after bot... , After their death, Musa first went to live wi... his Aunt Hadija. Although too young to fully unde...S. And with each passing year, these children begi...
Other Medicine News:Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 2Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 3Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 4Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 5Health News:Independent Audit of Global Child Immunizations Urged 2Health News:Sex difference on spatial skill test linked to brain structure 2Health News:Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine(R) 2Health News:FloBeds Develops Nation's First 'For Women Only' Mattress 2Health News:CCF Connects Parents With Their Children Through the Power of a Memory 2
VascoStim 2F
B 3.2 Bipolar Ventricular Lead
CapSure Novus
Impulse
Medicine Products: